Investor Advisory Board

Mark Booth
Chief Commercial Officer
Orexigen Therapeutics

Mark Colella
Managing Director, Private Equity
Stamos Capital

Steve Elms
Managing Partner
Aisling Capital

David Flores
President & CEO
BioCentury

Valerie Friedman
Principal
Bracebridge Capital, LLC

Marc-Henri Galletti
Managing Director
Longitude Capital

Tassos Gianakakos
CEO
MyoKardia

Winton Gibbons
President & CEO
Siloam Biosciences

Arthur Holden
Chairman and CEO, Pharmaceutical Biomedical Research Consortium, Ltd.
iSAEC Consortium

Adam Koopersmith
Partner
Pritzker Group

Michael Liang
Partner
RW Baird

Scott Minick
CEO, ARCH Venture Partners

Evan Norton
Managing Director
Abbott Ventures Inc.

H. Daniel Perez, MD
President and CEO, and Chairman of the Board
Naia Limited

Norbert Riedel, Ph.D.
President and CEO
Aptinyx, Inc.

Peter Shagory
Executive VP, Strategy & Corporate Development
CONMED

Geeta Vemuri
VP, Head of Baxter Ventures
Baxalta Corp

Sona Wang
Managing Director
Ceres Venture Fund

Dan Watkins
Managing Director
Mercury Fund